Coronary revascularization trends in the United States, 2001-2008

Andrew J Epstein1, Daniel Polsky, Feifei Yang

  • 1Department of Veterans Affairs' Center for Health Equity Research and Promotion, Philadelphia, Pennsylvania, USA.

JAMA
|May 5, 2011
PubMed

Insights

Coronary revascularization rates decreased significantly, with coronary artery bypass graft (CABG) surgery utilization declining while percutaneous coronary interventions (PCI) remained stable between 2001 and 2008 in US hospitals.

Area of Science:

  • Cardiovascular Medicine
  • Health Services Research
  • Interventional Cardiology

Background:

  • Coronary revascularization is a common U.S. hospital procedure.
  • The impact of new technologies, trial evidence, and guidelines on revascularization trends is unclear.

Purpose of the Study:

  • To analyze national trends in the rates and types of coronary revascularizations.
  • Examine changes in coronary artery bypass graft (CABG) surgery and percutaneous coronary intervention (PCI) utilization.

Main Methods:

  • Serial cross-sectional study of US hospitalizations from 2001-2008.
  • Utilized Healthcare Cost and Utilization Project's Nationwide Inpatient Sample and Medicare claims.
  • Analyzed annual procedure rates for CABG surgery and PCI.

Main Results:

  • Overall coronary revascularization rates decreased by 15% from 2001-2002 to 2007-2008.
  • Coronary artery bypass graft (CABG) surgery rates declined significantly, while percutaneous coronary intervention (PCI) rates remained stable.
  • The number of hospitals performing CABG surgery increased, but the median caseload per hospital decreased, with more hospitals performing fewer procedures.

Conclusions:

  • Coronary artery bypass graft (CABG) surgery utilization substantially decreased in US hospitals between 2001 and 2008.
  • Percutaneous coronary intervention (PCI) utilization rates remained unchanged during the same period.
  • Trends suggest a shift in revascularization strategies, with declining CABG surgery use despite increased PCI hospital availability.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...